Retraction
Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer
Paper Information
Record ID:
34424
Author(s):
Journal:
Publication Date:
June 15, 2018
Retraction Date:
December 03, 2021
(4.0 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institution:
Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (20)
20
Total Citations7
Post-Retraction(35.0%)
13
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
1
After 2+ years
1287
Days since retraction (latest)
ARHGAP36 serves as a diagnostic and therapeutic marker that mediates immune escape and promotes thyroid cancer metastasis
Liyun Yang, Junzhi Liu, Yuhuan Gao et al. (5 authors)
Biomedical Reports
Open Access
Published: Jun 2025
1287 days after retraction
Upregulation of ARHGAP9 is correlated with poor prognosis and immune infiltration in clear cell renal cell carcinoma
Yu-Ling Xiong, Chao Peng, Yue Tian
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2023
639 days after retraction
ARHGAP9 knockdown promotes lung adenocarcinoma metastasis by activating Wnt/β-catenin signaling pathway via suppressing DKK2
Wenping Song, Xuan Wu, Cheng Cheng et al. (6 authors)
Genomics
Open Access
Published: Jul 2023
9 citations
9 citations
590 days after retraction
Chromosome 12
Yamini Chandraprakash, Ravi Gor, Saurav Panicker et al. (4 authors)
BENTHAM SCIENCE PUBLISHERS eBooks
Published: Jul 2023
583 days after retraction
Influence of the Postmortem/Storage Time of Human Corneas on the Properties of Cultured Limbal Epithelial Cells
Gaëtan Le‐Bel, Pascale Desjardins, Christelle Gross et al. (7 authors)
Cells
Open Access
Published: Aug 2022
3 citations
3 citations
271 days after retraction
Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
Lin Han, Kun Wang, Yuxin Xiong et al. (12 authors)
Frontiers in Immunology
Open Access
Published: Feb 2022
38 citations
38 citations
61 days after retraction
GATA binding protein 5 (GATA5) induces Rho GTPase activating protein 9 (ARHGAP9) to inhibit the malignant process of lung adenocarcinoma cells
Wenfei Ji, Lili Zhang, Hongjun Zhu
Bioengineered
Open Access
Published: Jan 2022
7 citations
7 citations
46 days after retraction
Effect of Rho GTPase activating protein 9 combined with preoperative ratio of platelet distribution width to platelet count on prognosis of patients with serous ovarian cancer
Yang Shen, Haibo Xu, Zhihong Guan et al. (6 authors)
Translational Cancer Research
Open Access
Published: Oct 2021
5 citations
5 citations
63 days before retraction
B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein
Yu Pu, Li Zhu, Kang Cui et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Sep 2021
9 citations
9 citations
81 days before retraction
Rho GTPase Activating Protein 9 (ARHGAP9) in Human Cancers
Wenzhou Zhang, Liang Li, Wenping Song et al. (10 authors)
Recent Patents on Anti-Cancer Drug Discovery
Published: Aug 2021
4 citations
4 citations
116 days before retraction
<scp>SOX4</scp>‐induced upregulation of <scp>ARHGAP9</scp> promotes the progression of acute myeloid leukemia
Xin He, Haizhu Zou, Fengyu Wang
Drug Development Research
Published: Jun 2021
9 citations
9 citations
164 days before retraction
[MiR- 4719 inhibits migration and invasion of human breast cancer cells via targeting ARHGAP36].
Q Li, Yongming Qiu, Tong Huan Jin et al. (5 authors)
PubMed
Published: Jun 2021
1 citation
1 citation
166 days before retraction
The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia
Caixia Han, Shujiao He, Ruiqi Wang et al. (9 authors)
Journal of Translational Medicine
Open Access
Published: Feb 2021
14 citations
14 citations
294 days before retraction
Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells
Shahinda S. R. Alsayed, Amreena Suri, Anders W. Bailey et al. (10 authors)
RSC Medicinal Chemistry
Open Access
Published: Jan 2021
4 citations
4 citations
336 days before retraction
Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells <i>in vitro</i> and <i>in vivo</i>
Nirmala Jagadish, Sonika Devi, Namita Gupta et al. (5 authors)
Tumor Biology
Published: Apr 2020
6 citations
6 citations
611 days before retraction
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Wen-ping Song, Si Zheng, Hong-juan Yao et al. (10 authors)
BMC Ophthalmology
Open Access
Published: Mar 2020
17 citations
17 citations
637 days before retraction
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Wenping Song, Si Zheng, Hong-Juan Yao et al. (10 authors)
Research Square (Research Square)
Open Access
Published: Jan 2020
1 citation
1 citation
694 days before retraction
Paper citing Silencing ARHGAP9 correlates with the risk of brea...
Unknown Authors
Unknown Journal
Published: Jan 2020
694 days before retraction
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
Xuan‐Mei Piao, Pildu Jeong, Chunri Yan et al. (16 authors)
Oncology Letters
Open Access
Published: Nov 2019
16 citations
16 citations
745 days before retraction
Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer
Wei‐xian Chen, Ming Lou, Lin Cheng et al. (8 authors)
Oncology Letters
Open Access
Published: Oct 2019
25 citations
25 citations
793 days before retraction
Quick Stats
Total Citations:
20
Years Since Retraction:
4.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025